SEC Form 13F
| Report period | 2024-12-31 |
|---|---|
| Publicly available | 2025-02-15 |
| Reported value | $56,800,164 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ANNEXON INC | ANNX | COM | $37,992,903 | 7,406,024 |
| AKEBIA THERAPEUTICS INC | AKBA | COM | $10,921,021 | 5,747,906 |
| VERONA PHARMA PLC | VRNA | SPONSORED ADS | $4,086,720 | 88,000 |
| AMERICAN WELL CORP | AMWL | COM CL A NEW | $3,797,441 | 523,785 |
| AADI BIOSCIENCE INC | AADI | COM | $2,079 | 659 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.